封面
市场调查报告书
商品编码
1980750

全球生物可吸收植入市场规模、份额、趋势和成长分析报告(2026-2034年)

Global Bioresorbable Implants Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 147 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计生物可吸收植入市场将从 2025 年的 71.6 亿美元成长到 2034 年的 158.3 亿美元,2026 年至 2034 年的复合年增长率为 9.21%。

随着医疗技术朝着以患者为中心、微创的治疗方案发展,全球生物可吸收植入市场正蓬勃发展。生物可吸收植入旨在完成其预期功能后在体内逐渐溶解,无需手术取出。这些植入广泛应用于整形外科、心血管医学和牙科,能够提高患者的舒适度并降低长期併发症的风险。

市场成长的驱动力在于对先进医疗植入日益增长的需求,以及人们对生物可吸收材料优势的认识不断提高。生物材料和聚合物技术的创新使得新型植入物的研发成为可能,植入能够在癒合过程中提供结构支撑,并在体内安全地降解。由于这些解决方案能够缩短恢復时间并最大限度地减少再次手术的需求,医疗专业人员正越来越多地采用它们。

随着研究不断拓展生物可吸收材料的应用范围,全球生物可吸收植入市场前景十分光明。製造商正大力投资研发新一代植入,以提升其强度、耐久性和生物相容性。随着医疗基础设施的不断完善,新兴市场也有望迎来显着的成长机会。在以患者为中心的先进医疗技术需求日益增长的背景下,生物可吸收植入有望在现代外科手术中发挥至关重要的作用。

目录

第一章:引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章:全球生物可吸收植入市场:依材料类型划分

  • 市场分析、洞察与预测
  • 金属
  • 聚合物

第五章:全球生物可吸收植入市场:依应用领域划分

  • 市场分析、洞察与预测
  • 整形外科
  • 循环系统
  • 其他的

第六章 全球生物可吸收植入市场:依最终用户划分

  • 市场分析、洞察与预测
  • 医院
  • 专科诊所
  • 门诊手术中心
  • 其他的

第七章 全球生物可吸收植入市场:依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第八章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴(根据现有资讯)
  • 市场占有率和市场定位分析(基于现有资讯)
  • 供应商情况(基于现有资讯)
  • 策略规划

第九章:公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Abbott Laboratories
    • Medtronic Plc
    • Johnson & Johnson
    • Stryker Corporation
    • Zimmer Biomet Holdings Inc
    • Smith & Nephew Plc
    • Boston Scientific Corporation
    • Biotronik SE & Co. KG
    • Terumo Corporation
    • Arthrex Inc
    • Corbion NV
    • DSM Biomedical
    • WL Gore & Associates Inc
    • Amaranth Medical Inc
    • Bioretec Ltd
简介目录
Product Code: VMR112115226

The Bioresorbable Implants Market size is expected to reach USD 15.83 Billion in 2034 from USD 7.16 Billion (2025) growing at a CAGR of 9.21% during 2026-2034.

The Global Bioresorbable Implants Market is gaining momentum as medical technology advances toward more patient-friendly and minimally invasive treatment solutions. Bioresorbable implants are designed to gradually dissolve within the body after fulfilling their intended function, eliminating the need for surgical removal. These implants are widely used in orthopedic, cardiovascular, and dental procedures, offering improved patient comfort and reduced risk of long-term complications.

Market growth is driven by increasing demand for advanced medical implants and rising awareness about the benefits of bioresorbable materials. Innovations in biomaterials and polymer technology have enabled the development of implants that provide structural support during healing and then safely degrade within the body. Healthcare providers are increasingly adopting these solutions due to their ability to improve recovery times and minimize the need for follow-up surgeries.

The future outlook for the Global Bioresorbable Implants Market is highly promising as research continues to expand the applications of bioresorbable materials. Manufacturers are investing heavily in developing next-generation implants with enhanced strength, durability, and biocompatibility. Emerging markets are also expected to offer significant growth opportunities as healthcare infrastructure improves. As demand for advanced and patient-centric medical technologies rises, bioresorbable implants are expected to play a crucial role in modern surgical practices.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Material Type

  • Metallic
  • Polymer

By Application

  • Orthopedic
  • Cardiovascular
  • Others

By End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

COMPANIES PROFILED

  • Abbott Laboratories, Medtronic plc, Johnson Johnson, Stryker Corporation, Zimmer Biomet Holdings Inc, Smith Nephew plc, Boston Scientific Corporation, Biotronik SE Co KG, Terumo Corporation, Arthrex Inc, Corbion NV, DSM Biomedical, W L Gore Associates Inc, Amaranth Medical Inc, Bioretec Ltd
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIORESORBABLE IMPLANTS MARKET: BY MATERIAL TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Material Type
  • 4.2. Metallic Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Polymer Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIORESORBABLE IMPLANTS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Orthopedic Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Cardiovascular Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIORESORBABLE IMPLANTS MARKET: BY END USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIORESORBABLE IMPLANTS MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Material Type
    • 7.2.2 By Application
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Material Type
    • 7.3.2 By Application
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Material Type
    • 7.4.2 By Application
    • 7.4.3 By End User
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Material Type
    • 7.5.2 By Application
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Material Type
    • 7.6.2 By Application
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BIORESORBABLE IMPLANTS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Abbott Laboratories
    • 9.2.2 Medtronic Plc
    • 9.2.3 Johnson & Johnson
    • 9.2.4 Stryker Corporation
    • 9.2.5 Zimmer Biomet Holdings Inc
    • 9.2.6 Smith & Nephew Plc
    • 9.2.7 Boston Scientific Corporation
    • 9.2.8 Biotronik SE & Co. KG
    • 9.2.9 Terumo Corporation
    • 9.2.10 Arthrex Inc
    • 9.2.11 Corbion N.V
    • 9.2.12 DSM Biomedical
    • 9.2.13 W. L. Gore & Associates Inc
    • 9.2.14 Amaranth Medical Inc
    • 9.2.15 Bioretec Ltd